PAX5 fusion genes in acute lymphoblastic leukemia: A literature review

被引：5
|
作者：
Fouad, Fatma Mohamed [1 ,2 ,4 ]
Eid, Jehane. I. I. [3 ]
机构：
[1] Sultan Qaboos Univ, Coll Sci, Biol Dept, Muscat, Oman
[2] Cairo Univ, Fac Sci, Chem Dept, Biotechnol Bimol Chem program, Giza, Egypt
[3] Cairo Univ, Fac Sci, Zool Dept, Giza, Egypt
[4] Sultan Qaboos Univ, Coll Sci, Biol Dept, POB 36, Muscat 123, Oman
来源：
MEDICINE | 2023年 / 102卷 / 20期
关键词：
ALL; B-ALL; fusion; PAX5; B-CELL DEVELOPMENT; TRANSLOCATIONS; PRECURSOR; PROTEIN; FAMILY; RISK; ACTS; IDENTIFICATION; REGULATOR; DIVERSITY;
D O I：
10.1097/MD.0000000000033836
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Acute lymphoblastic leukemia (ALL) is a common cancer affecting children worldwide. The development of ALL is driven by several genes, some of which can be targeted for treatment by inhibiting gene fusions. PAX5 is frequently mutated in ALL and is involved in chromosomal rearrangements and translocations. Mutations in PAX5 interact with other genes, such as ETV6 and FOXP1, which influence B-cell development. PAX5/ETV6 has been observed in both B-ALL patients and a mouse model. The interaction between PAX5 and FOXP1 negatively suppresses the Pax5 gene in B-ALL patients.Additionally, ELN and PML genes have been found to fuse with PAX5, leading to adverse effects on B-cell differentiation. ELN-PAX5 interaction results in the decreased expression of LEF1, MB1, and BLNK, while PML-PAX5 is critical in the early stages of leukemia. PAX5 fusion genes prevent the transcription of the PAX5 gene, making it an essential target gene for the study of leukemia progression and the diagnosis of B-ALL.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
    Fazio, Grazia
    Bresolin, Silvia
    Silvestri, Daniela
    Quadri, Manuel
    Saitta, Claudia
    Vendramini, Elena
    Buldini, Barbara
    Palmi, Chiara
    Bardini, Michela
    Grioni, Andrea
    Rigamonti, Silvia
    Galbiati, Marta
    Mecca, Stefano
    Savino, Angela Maria
    Peloso, Alberto
    Tu, Jia-Wey
    Bhatia, Sanil
    Borkhardt, Arndt
    Micalizzi, Concetta
    Lo Nigro, Luca
    Locatelli, Franco
    Conter, Valentino
    Rizzari, Carmelo
    Valsecchi, Maria Grazia
    te Kronnie, Geertruij
    Biondi, Andrea
    Cazzaniga, Giovanni
    EBIOMEDICINE, 2022, 83
  • [22] PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
    J Familiades
    M Bousquet
    M Lafage-Pochitaloff
    M-C Béné
    K Beldjord
    J De Vos
    N Dastugue
    E Coyaud
    S Struski
    C Quelen
    N Prade-Houdellier
    S Dobbelstein
    J-M Cayuela
    J Soulier
    N Grardel
    C Preudhomme
    H Cavé
    O Blanchet
    V Lhéritier
    A Delannoy
    Y Chalandon
    N Ifrah
    A Pigneux
    P Brousset
    E A Macintyre
    F Huguet
    H Dombret
    C Broccardo
    É Delabesse
    Leukemia, 2009, 23 : 1989 - 1998
  • [23] PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
    Familiades, J.
    Bousquet, M.
    Lafage-Pochitaloff, M.
    Bene, M. -C
    Beldjord, K.
    De Vos, J.
    Dastugue, N.
    Coyaud, E.
    Struski, S.
    Quelen, C.
    Prade-Houdellier, N.
    Dobbelstein, S.
    Cayuela, J-M
    Soulier, J.
    Grardel, N.
    Preudhomme, C.
    Cave, H.
    Blanchet, O.
    Lheritier, V.
    Delannoy, A.
    Chalandon, Y.
    Ifrah, N.
    Pigneux, A.
    Brousset, P.
    Macintyre, E. A.
    Huguet, F.
    Dombret, H.
    Broccardo, C.
    Delabesse, E.
    LEUKEMIA, 2009, 23 (11) : 1989 - 1998
  • [24] Rearrangement and deletion of the PAX5 gene in pediatric acute B-Cell lineage lymphoblastic leukemia
    Kawamata, Norihiko
    Ogawa, Seishi
    Zimmermann, Martin
    Sanada, Masashi
    Hemminki, Kari
    Yamatomo, Go
    Nannya, Yasuhito
    Koehler, Rolf
    Flohr, Thomas
    Miller, Carl W.
    Harbott, Jochen
    Ludwig, Wolf-Dieter
    Stanulla, Martin
    Schrappe, Martin
    Bartram, Claus R.
    Koeffler, Phillip H.
    BLOOD, 2007, 110 (11) : 298A - 298A
  • [25] PAX5 LOSS IMPOSES A REVERSIBLE DIFFERENTIATION BLOCK IN B-PROGENITOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Liu, Grace
    Cimmino, Luisa
    Jude, Julian
    Hu, Yifang
    Kartal, Mutlu
    Witkowski, Matthew
    McKenzie, Mark
    Best, Sarah
    Tuohey, Laura
    Mullighan, Charles
    Farrar, Michael
    Nutt, Stephen
    Smyth, Gordon
    Zuber, Johannes
    Dickins, Ross
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (08) : S46 - S46
  • [26] PAX5 LOSS IMPOSES A REVERSIBLE DIFFERENTIATION BLOCK IN B-PROGENITOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Dickins, Ross
    Liu, Grace
    Cimmino, Luisa
    Hu, Yifang
    Best, Sarah
    Tuohey, Laura
    Farrar, Michael
    Nutt, Stephen
    Smyth, Gordon
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S16 - S16
  • [27] PRE-CLINICAL STUDIES ON PAX5 FUSION GENE TARGETING IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Saitta, C.
    Mecca, S.
    Savino, A.
    Bardini, M.
    Palmi, C.
    Biondi, A.
    Fazio, G.
    Cazzaniga, G.
    HAEMATOLOGICA, 2018, 103 : S105 - S105
  • [28] A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5
    Bousquet, Marina
    Broccardo, Cyril
    Quelen, Cathy
    Meggetto, Fabienne
    Kuhlein, Emilienne
    Delsol, Georges
    Dastugue, Nicole
    Brousset, Pierre
    BLOOD, 2007, 109 (08) : 3417 - 3423
  • [29] Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia
    Li, Yan
    Zhang, Qin
    Shao, Haigang
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5599 - 5605
  • [30] Germline aberrations of PAX5 cause susceptibility to pre-B cell acute lymphoblastic leukemia
    Miething, C.
    Shah, S.
    Schrader, K.
    Waanders, E.
    Timms, A.
    Vijay, J.
    Sandlund, J.
    Lowe, S.
    Horwitz, M.
    Mullighan, C.
    Offit, K.
    ONKOLOGIE, 2013, 36 : 52 - 52
12345